Arbor, a national telehealth service, has launched two compounded GLP‑1 weight‑management programs that begin at $99 per month. The plans are designed to give patients access to weekly injectable medications—semaglutide or tirzepatide—under the supervision of licensed clinicians, while keeping costs predictable.
Program options and pricing
Compounded semaglutide is offered at a base rate of $99 per month. The medication works by reducing appetite and helping users manage cravings as part of a physician‑guided weight‑loss plan.
Compounded tirzepatide starts at $149 per month. This drug combines GLP‑1 and GIP receptor activity, offering an alternative pathway for appetite control and weight‑loss goals, also under clinical supervision.
What sets Arbor apart
Arbor emphasizes a simple, locked‑in pricing model. Unlike some programs that raise monthly fees as dosage increases, Arbor’s rate remains steady after enrollment. The monthly fee includes medication (when prescribed), provider consultations, ongoing clinical check‑ins, dose adjustments, patient support and free shipping. Plans are eligible for HSA/FSA reimbursement and do not require insurance coverage.
How the service works
Interested individuals begin by completing an online health assessment. A licensed U.S. clinician reviews the submitted medical information and determines whether a GLP‑1 therapy is appropriate. If a prescription is issued, a licensed pharmacy compounds the medication and ships it directly to the patient’s home.
The typical process follows these steps:
- Complete the online health questionnaire.
- Receive a clinical review from a licensed provider.
- Obtain a prescription if medically appropriate.
- Receive the compounded medication via home delivery.
- Continue treatment with regular provider support and check‑ins.
Arbor notes that its clinicians are independent of the platform; medical evaluations are performed by qualified providers who decide on treatment suitability. Because the medications are compounded, they have not undergone FDA review for safety or effectiveness, and state‑by‑state consultation requirements may vary.
Considerations for patients
Potential users should be aware that, as with any prescription medication, GLP‑1 therapies carry possible side effects and are not suitable for everyone. The telehealth model relies on self‑reported health information and remote clinical assessment, which may differ from in‑person evaluations. Patients are encouraged to discuss any concerns with their prescribing clinician and to verify that their insurance or health‑savings accounts can be applied toward the monthly fee.
Broader context
GLP‑1 medications have become a focal point in weight‑management discussions due to their effectiveness, but high out‑of‑pocket costs and insurance barriers have limited access for many. Arbor’s pricing structure aims to lower those barriers, offering a more affordable route for eligible adults seeking physician‑supervised weight‑loss support.
For those interested, enrollment can be completed in roughly 90 seconds, and the company promises ongoing clinical oversight throughout the treatment period.
Original reporting: Las Cruces Sun News (HLL/CB) — read the source article.
